Healthtracka, a Nigerian startup that offers convenient at-home lab tests, raised $1.5 Million in pre-seed financing.
Venture capital investors Ingressive Capital & Hustle Fund led this round, along with participation by angel investors Alunmi Angels Alliance & Flying Doctors.
Founded in May 2021 by Ifeoluwa Dare-Johnson and Victor Amusan in Lagos, Healthtracka allows users to book tests on its website, have their samples collected at their homes and access their results on their email addresses.
Healthtracka partners with medical laboratories—3 at the moment: vCare Diagnostics, Lancet Laboratories, and Afriglobal Medicare—who provide them with phlebotomists who go down to patients’ houses to collect samples, analyse the samples and return results in 2 days.
Dare-Johnson stated that telemedicine platforms used to only offer consultation services, but would refer patients to hospitals for diagnostics. Now they can now order lab tests for the patient using Healthtracka’s API.
Users can go on Healthtracka’s website and book lab tests ranging from fertility and STD tests to full blood count and COVID tests. Healthtracka offers specialist consultations after patients have received their results.
Dare-Johnson explained that the pandemic was crucial to Healthtracka’s growth, during the pandemic, Healthtracka started offering COVID-19 tests. “It was a trying time where people needed the comfort and the assurance that they could access healthcare remotely and safely,” she said
Dare-Johnson stated that privacy is another reason their clients patronise them, as they protect clients from the social stigma that comes along with visiting the hospital to have tests done for sexually transmitted disease (STD).
Healthtracka currently has 50 different medical tests, which it has offered 7,000 times to 5,000 users at home, using a network of 700 phlebotomists, across 7 Nigerian cities—Lagos, Abuja, Port Harcourt, Benin, Kaduna, Ilorin, and Ibadan.
“Ifeoluwa is hungry and very bright. Not only did we anonymously use Healthtracka’s services in diligence and had a 10/10 experience, but we also recognised truly what this could become across the continent, even from just interacting with her team for tests,” Ingressive Capital’s founder, Maya Horgan Famodu, said in a statement. “The product is high-quality, on time, affordable, and unlocking the door for a healthier Africa.”
Healthtracka’s funding will also power its growth plans, which include introducing new product features and expanding its at-home lab testing services into Kenya and Ghana in the coming months. It plans to increase its offerings by launching an API, which will enable both traditional and telemedicine providers to offer at home lab testing.
“We have realised, especially in the countries we are expanding to, that the infrastructure deficit problem is the same. Our experience in offering diagnostics in Nigeria gives us confidence that we can tackle this problem in other markets as well,” she added.
“We are reshaping culture to make lab testing as seamless as ordering a dress online. I think that we are able to scale this across Africa, especially in the places that need it the most.”